Obesity Raises Odds for Recurrence in Breast Cancer Survivors: The Heavy Burden

Increased Risk of Recurrence in Breast Cancer Survivors with Obesity

Obesity increases chances of breast cancer coming back.

Many breast cancer survivors take a hormonal drug after cancer treatment to stave off a recurrence, but new research suggests these drugs may be less effective in women who are obese. At first glance, you might think, “A hormonal drug? Sounds magical! They must be pretty effective!” Well, hold onto your seat because things aren’t as rosy as they seem.

Breast cancer cells in hormone-positive breast cancers are fueled by the female sex hormone estrogen. But fear not, there are medications called aromatase inhibitors that lower estrogen levels by stopping an enzyme in fat tissue called aromatase from changing other hormones into estrogen. It’s like unleashing a superhero squad to battle against estrogen.

However, it turns out that these superhero drugs might not be as powerful for women who are obese. In fact, a recent study found that obese breast cancer survivors were 18% more likely to have a recurrence even when taking an aromatase inhibitor. And things get even scarier for survivors who are severely obese – their risk was even higher! It’s a bit like fighting a raging fire with a garden hose.

Oh, but before you start panicking, let me reassure you. According to the study author, Sixten Harborg, “Treatment with aromatase inhibitors is still the treatment choice for this patient group and lowers the rate of breast cancer recurrence and [death] in this patient group.” Phew, I can hear the sighs of relief.

Now, let’s dive a bit deeper into the mystery of how obesity increases the risk of breast cancer recurrence in women taking aromatase inhibitors. It seems that obesity can be a tricky fellow, affecting drug metabolism and distribution like a mischievous gremlin in your body. As it turns out, fat cells store estrogen, and as you can imagine, women who are obese have more fat tissue. So it’s like these aromatase inhibitors are playing a game of hide-and-seek with estrogen, but the fat tissue is a master of disguise.

• Newsflash: Serotonin and the Lingering COVID Mystery
• A Doctor’s Empathy: A Key to Breast Cancer Care
• Swing that Golf Club or Go for a Walk: Boost Your Brain Power!

But fear not, my dear readers, for Sixten Harborg has come to the rescue! He says, “The underlying mechanisms are multifactorial, and further clinical studies to understand how obesity is linked to breast cancer progression are needed.” So, the scientific league of extraordinary researchers will continue to unravel the mysterious connection between obesity and breast cancer recurrence. Stay tuned for more exciting updates!

In the study, researchers analyzed data on 13,230 breast cancer survivors who were taking aromatase inhibitors to prevent a recurrence. Of these, there were 1,587 recurrences that took place during slightly more than six years of follow-up. The study found that women who were obese or severely obese and were treated with aromatase inhibitors were more likely to have a recurrence of their cancer than their counterparts who were of normal weight. It’s like a never-ending battle between the forces of good (aromatase inhibitors) and evil (obesity).

But wait, there’s more! Women who were overweight, but not obese, did have a greater risk of breast cancer recurrence, but the results were not considered statistically significant. It’s like being caught in a gray area, where the risk is lurking in the shadows.

While the evidence mounts, it’s essential to remember that weight affects the risk of breast cancer recurrence in women taking aromatase inhibitors. Dr. Vivian Jolley Bea, a section chief of breast surgical oncology, says, “Maintaining a normal weight, eating a healthy diet, and getting regular exercise can help lower the risk of a breast cancer recurrence risk.” So, dear readers, arm yourselves with knowledge and embrace a fit and healthy lifestyle to fight off the dangers of obesity and breast cancer recurrence.

Now, let’s take a moment to acknowledge the underlying seriousness of obesity and its impact on cancer. Dr. Carmen Calfa, a breast medical oncologist, points out, “There is overwhelming evidence linking obesity to 13 cancer types, and obesity also increases the risk of dying from cancer.” It’s like having a ticking time bomb hidden within ourselves.

But here’s the good news: body weight is modifiable, unlike genetics and other risk factors. Dr. Calfa emphasizes the importance of programs that incorporate nutrition and exercise after a cancer diagnosis. So, my dear readers, let’s take control of our destiny and reduce the risk of breast cancer recurrence by making healthier choices and engaging in regular physical activity. We have the power to write our happy ending.

To wrap it all up, let’s remember that knowledge is power. Being aware of the impact of weight on breast cancer recurrence can empower us to make informed decisions about our health. So, take a moment to digest this information, share it with your loved ones, and let’s work together towards a future free from the heavy burden of obesity and its potential consequences.

More information on breast cancer treatments

Readers, have you or someone you know been affected by obesity and breast cancer? Share your experiences and insights in the comments below. Let’s support each other in this journey towards better health!